CLPTM1L and non-Hodgkin lymphoma: Finally, we used a commercially available anti-CLPTM1L antibody to perform immunohistochemistry on human tonsil and on bone marrow from patients with either non-Hodgkin’s lymphoma (non-involved bone marrow) or MM (Figure 4D).